Shareholders meet on Hatri Pharma merger; voting results pending

Board & Shareholder Meetings View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.5%Reaction day

₹14.65

prior close

₹13.50

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-4.9% vs market

Pharmaceuticals peers, median of 174sector+1.2%-5.7% vs sector

On the reaction day the stock moved 4.9 pts less than Nifty Microcap 250 and 5.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+10.4

10m

+10.4

15m

+10.4

30m

+10.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.5+0.4-4.9+1.2-5.7

Next day

-4.4+2.1-6.6+3.1-7.6

-11.3+2.2-13.5+4.8-16.1

-8.3+2.9-11.2+4.7-13.1

-8.5+0.3-8.8+3.4-11.9

-6.9+1.8-8.7+3.3-10.1

-2.3+4.2-6.5+5.0-7.2

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 174Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

At a court-convened meeting on October 24, 2026, 40 members attended by video conference and confirmed the quorum for Venmax's proposed merger with Hatri Pharma Private Limited. Remote voting ran from October 21 to 23, with voting also allowed during the meeting. The chair discussed the scheme's rationale, valuation and exchange ratio. Final results were awaited and were to be published on BSE and the company website.

Likely market impact

The merger was not yet confirmed because voting results were pending. Shareholders still face uncertainty over final approval and the merger's impact on the stock.